Applied UV, Inc.: Nasdaq/NYSE listing notice — Applied UV receives Nasdaq bid price deficiency notice; 180 days to regain compliance

Applied UV, Inc.

Received Nasdaq notice: common stock (AUVI) failed $1.00 minimum bid for 30 consecutive biz days through Apr 12, 2023.
Company has 180 calendar days, until Oct 10, 2023, to regain compliance with Nasdaq Bid Price Rule.
If still noncompliant by Oct 10, may qualify for additional 180-day cure period if other listing standards met.
Company evaluating options to regain compliance; no assurance of success.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Applied UV, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

April 12, 2023, the common stock of the Company had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until October 10, 2023 (the “Compliance Period”), to regain compliance with the Bid Price Rule. If the Company does not regain compliance with the Bid Price Rule by October 10, 2023, the Company may be eligible for an additional 180-day period

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001607062-23-000199

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.